Suppr超能文献

肠道透析在尿毒症保守治疗中的应用。

Intestinal dialysis for conservative management of Uremia.

机构信息

Renal Division, Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.

出版信息

Curr Opin Nephrol Hypertens. 2020 Jan;29(1):64-70. doi: 10.1097/MNH.0000000000000571.

Abstract

PURPOSE OF REVIEW

Renal replacement therapies, such as hemodialysis are invasive and impose significant financial burden as well as burden on quality of life. Conservative and 'gentler' forms of renal replacement therapy for the frail and palliative care patient is an unmet medical need.

RECENT FINDINGS

The treatment of uremia using the gut as a substitute for the kidney has been proposed but is not practiced widely because of proven lack of long-term mortality benefit coupled with complications like edema and hyperchloremia. Mounting evidence showed that endotoxins from gastrointestinal tract are a major source of chronic inflammation in chronic kidney disease (CKD). The high load of nitrogenous waste elimination through the bowel could potentially serve as an alternative modality to remove uremic wastes especially in people who opt for conservative management for end-stage renal disease with some recent studies in Iran and China showing promising benefits in uremia.

SUMMARY

In this review, we will discuss the history, recent evidence and potential of these therapies and their implications in CKD for conservative and easy management of uremia.

摘要

目的综述

肾脏替代疗法,如血液透析,具有侵袭性,会带来巨大的经济负担和生活质量负担。对于体弱和姑息治疗患者,保守和“温和”的肾脏替代疗法是未满足的医疗需求。

最近的发现

人们曾提出使用肠道替代肾脏来治疗尿毒症,但由于缺乏长期生存获益的证据,且存在水肿和高氯血症等并发症,因此并未广泛应用。越来越多的证据表明,肠道内的内毒素是慢性肾脏病(CKD)慢性炎症的主要来源。通过肠道清除大量氮废物的能力可能是一种替代方式,可以去除尿毒症废物,特别是对于那些选择保守治疗终末期肾病的患者,伊朗和中国的一些近期研究显示出了对尿毒症的有益作用。

总结

在这篇综述中,我们将讨论这些疗法的历史、最新证据和潜力,以及它们在 CKD 中的保守和简便的尿毒症管理中的意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验